Posted by SLS on January 18, 2009, at 3:49:20
In reply to any sign of it being released in canada » SLS, posted by iforgotmypassword on January 18, 2009, at 1:17:05
Good luck with nefazodone. I was unaware that Abilify exerted any effects at 5-HT2c. That is showing itself to be an interesting receptor. People sometimes overlook that Abilify is also a 5-HT1a partial agonist. The soon-to-be approved asenapine is an AP that acts as a 5-HT1a antagonist. I don't think I like that.
- Scott
> sorry, i don't mean to interrupt. it's a drug i may consider trying if i could get it easily enough. in the meantime, the good news is i may be able to get nefazodone sometime in the middle of next week, hoping for luck there. both drugs seem to have poorly explained interaction with the 5-HT2C receptor, for better or worse, both, or no significance at all... wish things were clearer in that department.
poster:SLS
thread:874627
URL: http://www.dr-bob.org/babble/20090104/msgs/874669.html